((((3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl)bis(azanediyl))bis(methylene))bis(2,1-phenylene))diboronic acid

Catalog No. :
ACUDTD719
CAS No. :
647864-09-3
Molecular Formula :
C34H28B2N2O7
Molecular Weight :
598.23

IUPAC Name:((((3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl)bis(azanediyl))bis(methylene))bis(2,1-phenylene))diboronic acid

((((3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl)bis(azanediyl))bis(methylene))bis(2,1-phenylene))diboronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((((3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl)bis(azanediyl))bis(methylene))bis(2,1-phenylene))diboronic acid
IUPAC Name((((3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl)bis(azanediyl))bis(methylene))bis(2,1-phenylene))diboronic acid
Molecular FormulaC34H28B2N2O7
Molecular Weight598.23
SMILESO=C1OC2(C3=CC=C(C=C3OC4=CC(=CC=C42)NCC=5C=CC=CC5B(O)O)NCC=6C=CC=CC6B(O)O)C=7C=CC=CC17
InChI KeyWOIRXWXVQDFVGH-UHFFFAOYSA-N
SynonymBoronic acid, B,B'-[(3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3',6'-diyl)bis(iminomethylene-2,1-phenylene)]bis-
CAS No.647864-09-3

Synthetic Route by SureRoute

1. ACUDTD719 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMSDY581 route compound structure diagram
    ACMSDY58140138-16-7 In Stock
  4. Then
  5. ACUDTD719 route product structure diagram
    ACUDTD719647864-09-3
Inquiry

2. ACUDTD719 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNCEY348 route compound structure diagram
    ACNCEY348248274-03-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUDTD719 route product structure diagram
    ACUDTD719647864-09-3
Inquiry

Comments (0)